Digital rectal exams (DREs) may not be useful as a primary screening tool for detecting prostate cancer, according to a new study out of Germany. The findings suggest that other methods, like prostate specific antigen (PSA) blood tests, may be better.
Photodynamic diagnosis-guided TURBT did not reduce 3-year recurrence rates of non–muscle-invasive bladder cancer in a real-world trial compared with white light-guided cystoscopy.
A large study from Germany found that digital rectal examination had low detection rates compared with prostate-specific antigen testing in men in their mid-to-late 40s.
Men with newly diagnosed non-metastatic prostate cancer who were randomly assigned to surgery, radiation, or active monitoring had similar overall and prostate cancer-specific survival rates after 15 years.